Hem › Agammaglobulinemi › Maryland
Kliniska studier för Agammaglobulinemi i Maryland
3 studier för Agammaglobulinemi söker deltagare vid platser i Maryland.
Officiell studietext (engelska)
Immune Regulation in Patients With Common Variable Immunodeficiency and Related Inborn Errors of Immunity (IEI)
- National Institutes of Health Clinical Center, Bethesda
RekryterarObservationsstudie
Ålder 2 till 120 · Alla kön · Uppdaterad 2 okt. 2026 · NCT00001244A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
- GC2202 Study Site 111, Bethesda
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 30 sep. 2026 · NCT05645107Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- Johns Hopkins Asthma & Allergy Center, Baltimore
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 21 sep. 2026 · NCT07648264Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.